Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic ...
Azenosertib median duration of response (mDOR) updated to 6.3 months in the ongoing DENALI Part 1b clinical trial in patients with ...
News-Medical.Net14 分钟
Engineered nano-aircraft carrier enhances tumor targeting and immune response
The researchers designed an efficient approach for fabricating engineered Pts-based nano-aircraft carriers with graded drug delivery and ECM degradation for precise cancer chemoimmunotherapy.